Overview

Evaluation of EXPAREL for Prolonged Postsurgical Analgesia in Subjects Undergoing Third Molar Extraction

Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
This is a Phase 3, randomized, double-blind, placebo-controlled study in subjects scheduled to undergo elective bilateral third molar extraction under local anesthesia. At least one lower mandibular third molar must involve full or partial bony impaction confirmed by visual or radiographic evidence.
Phase:
Phase 3
Details
Lead Sponsor:
Pacira Pharmaceuticals, Inc
Collaborator:
Lotus Clinical Research, LLC
Treatments:
Bupivacaine